Radius Health (RDUS) Misses Q2 EPS by 51c
Tweet
Share
E-mail
Get Alerts RDUS Hot Sheet
Join SI Premium – FREE
Radius Health (NASDAQ: RDUS) reported Q2 EPS of ($0.99), $0.51 worse than the analyst estimate of ($0.48). Revenue for the quarter came in at $696.22 million versus the consensus estimate of $696.22 million.
For earnings history and earnings-related data on Radius Health (RDUS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
- Varonis Said To Weigh Sale After Takeover Interest - Bloomberg
- Pfizer executive says China now leads Europe in drug innovation
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
